Abstract P108 Table
VariableAsthmatic (n  =  34) Mean (95% CI)Inflammatory (n  =  20) Mean (95% CI)Non-inflammatory (n  =  18) Mean (95% CI)Overall ANOVA
Age (years)49.9 (43.6 to 56.1)54.1 (45.9 to 62.2)50.2 (45.7 to 54.6)0.577
Duration rhinitis (years)15.9 (11.5 to 20.4)14.3 (6.3 to 22.3)17.7 (10.3 to 25.0)0.773
Exhaled NO (ppb)*34.3 (25.9 to 45.3)48.2 (36.0 to 64.5)15.4 (11.1 to 21.3)<0.005
Nasal NO (ppb)*386.0 (297.5 to 500.7)372.1 (274.1 to 504.1)413.3 (315.8 to 540.9)0.892
FEV1% predicted83.7 (78.2 to 89.1)101.1 (94.3 to 107.8)101.2 (94.0 to 108.4)<0.005
FEF25−75% predicted60.3 (52.0 to 68.6)83.6 (72.4 to 94.7)90.1 (77.7 to 102.4)<0.005
sReff % predicted*114.6 (92.2 to 142.4)81.8 (65.9 to 101.5)76.7 (64.2 to 91.6)0.012
Serum IgE (kU/l)*162.7 (91.2 to 290.1)93.6 (42.9 to 204.2)44.4 (25.6 to 77.0)0.011
Eosinophil count (cells/μl)*0.44 (0.36 to 0.53)0.35 (0.26 to 0.47)0.25 (0.19 to 0.33)<0.005
  • *Presented as geometric mean and 95% CI. ANOVA, analysis of variance; NO, nitric oxide; sReff, specific effective airway resistance.